|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.55 USD | +2.63% |
|
+4.77% | +40.67% |
| Market Cap | 552M 479M 448M 410M 774M 52.54B 784M 5.24B 2.06B 26.25B 2.07B 2.03B 87.37B | P/E 2026 * |
-2.62x | P/E 2027 * | -2.98x |
|---|---|---|---|---|---|
| Enterprise Value | 324M 281M 263M 241M 455M 30.87B 461M 3.08B 1.21B 15.42B 1.22B 1.19B 51.33B | EV / Sales 2026 * |
27.5x | EV / Sales 2027 * | 19.8x |
| Free-Float |
96.86% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: 4D Molecular Therapeutics, Inc.
| 1 day | +2.63% | ||
| 1 week | +4.77% | ||
| Current month | +3.63% | ||
| 1 month | -17.06% | ||
| 3 months | +1.25% | ||
| 6 months | +17.35% | ||
| Current year | +40.67% |
| 1 week | 9.66 |  | 10.69 |
| 1 month | 9.39 | | 13.39 |
| Current year | 6.96 | | 14 |
| 1 year | 5.33 | | 14 |
| 3 years | 2.24 | | 36.25 |
| 5 years | 2.24 | | 36.25 |
| 10 years | 2.24 | | 55.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Theresa Janke
COO | Chief Operating Officer | 51 | 2018-03-31 |
David Kirn
CEO | Chief Executive Officer | 64 | 2013-09-11 |
Scott Bizily
CMP | Compliance Officer | 54 | 2021-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
David Kirn
CHM | Chairman | 64 | 2013-09-11 |
Charles Theuer
BRD | Director/Board Member | 62 | 2015-11-30 |
Jacob Chacko
BRD | Director/Board Member | 47 | 2019-02-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/4/26 | Sell | Founder | -26,842 | 0.0513% | ||
| 8/3/26 | Sell | Founder | -12,415 | 0.0237% | ||
| 7/10/26 | Sell | Founder | -15,725 | 0.0301% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.63% | +4.77% | +84.12% | -41.81% | 552M | |
| +2.05% | +2.88% | +5.20% | +17.99% | 48.7B | |
| +0.26% | +2.93% | +439.43% | +533.80% | 42.05B | |
| -1.53% | -2.25% | +30.95% | +7.15% | 38.26B | |
| +0.69% | +2.40% | +10.48% | +63.05% | 37.5B | |
| +2.47% | +2.63% | +14.71% | +48.37% | 31.44B | |
| -0.47% | +1.16% | +35.93% | +126.09% | 16.33B | |
| +2.31% | -0.49% | - | - | 16.47B | |
| +1.20% | +3.76% | +7.64% | +20.44% | 13.98B | |
| -1.43% | -2.63% | +3.70% | -36.38% | 12.43B | |
| Average | +0.82% | +1.16% | +70.24% | +82.08% | 25.77B | |
| Weighted average by Cap. | +0.72% | +0.94% | +89.36% | +121.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11.78M 10.22M 9.57M 8.76M 16.53M 1.12B 16.75M 112M 43.95M 561M 44.23M 43.27M 1.87B | 17.62M 15.29M 14.32M 13.09M 24.72M 1.68B 25.04M 167M 65.72M 838M 66.14M 64.71M 2.79B |
| Net income | -279M -242M -226M -207M -391M -26.55B -396M -2.65B -1.04B -13.27B -1.05B -1.02B -44.15B | -290M -252M -236M -216M -407M -27.64B -413M -2.76B -1.08B -13.81B -1.09B -1.07B -45.97B |
| Net Debt | -227M -197M -185M -169M -319M -21.67B -323M -2.16B -849M -10.83B -854M -836M -36.03B | -203M -176M -165M -151M -285M -19.33B -288M -1.93B -757M -9.66B -762M -745M -32.14B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-06 | US$10.55 | +2.63% | 297,341 |
| 26-08-05 | US$10.28 | +0.19% | 664,783 |
| 26-08-04 | US$10.26 | +1.68% | 478,304 |
| 26-08-03 | US$10.09 | -0.88% | 463,747 |
| 26-07-31 | US$10.18 | +1.09% | 716,312 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FDMT Stock
Select your edition
All financial news and data tailored to specific country editions
